Recent studies highlight advancements in organ transplantation including normothermic regional perfusion (NRP) to improve organ viability, out-of-sequence organ allocation debates focusing on equity and efficiency, and multimedia educational tools enhancing living donation awareness. Additionally, Terumo’s $1.5 billion acquisition of Organox marks significant industry validation of organ preservation technology, potentially improving transplantation outcomes amid ongoing research into immune sensitization and allocation policies.